Jagsonpal Pharmaceuticals Limited — Financials & Forensics

NSE: JAGSNPHARM · BSE: 507789 · ISIN: INE048B01035

₹229.90

Closing price
19 Aug 2026

-7.5%

1-year price change

₹1,540 Cr

Market cap

35.7×

P/E ratio (trailing)

16.7%

Return on Equity (FY)

⚡ What you get within minutes of every filing

ISA

Indian Stock Alerts BOT

🚨 JAGSNPHARM — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add JAGSNPHARM to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

Loading chart…

Annual P&L snapshot

Line item	FY22	FY23	FY24	FY25	FY26
Revenue from operations	₹226 Cr	₹237 Cr	₹209 Cr	₹269 Cr	₹287 Cr
EBITDA	₹26 Cr	₹34 Cr	₹23 Cr	₹51 Cr	₹58 Cr
EBITDA margin	11.4%	14.4%	11.1%	19.0%	20.2%
Profit after tax	₹20 Cr	₹27 Cr	₹22 Cr	₹55 Cr	₹43 Cr

Source: Jagsonpal Pharmaceuticals Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

Recent filings by Jagsonpal Pharmaceuticals Limited

Change in Senior Management personnel of the Company
29 Jul 2026 · Management Change
Intimation for grant of Employee Stock Options
29 Jul 2026 · Regulatory Compliance
Press Release
29 Jul 2026 · Financial Results
Record Date
29 Jul 2026 · Corporate Action
Outcome of Board Meeting held on July 29, 2026 along with Unaudited (Standalone) Financial Results f
29 Jul 2026 · Financial Results

Never miss a filing again

Add stocks to watchlist

Get instant Telegram alerts

Get started — it's free →

14-day Pro trial included · No credit card required

About Jagsonpal Pharmaceuticals Limited on Indian Stock Alerts

Indian Stock Alerts tracks Jagsonpal Pharmaceuticals Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Jagsonpal Pharmaceuticals Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.